TherAchon is a Biotechnology company that was established in 2014 and focuses on rare diseases. It is developing a drug for achondroplasia in particular: TA-46, which is planned to go onto phase I clinical trials in 2019 [1]. In order to … Continue reading
July 13, 2018
by inesp.alves
4 Comments